Evaluation of 3-V Bioscience-2640 to Reduce de Novo Lipogenesis in Subjects With Characteristics of Metabolic Syndrome

计划入组 12 人 · 首次发布于 2016 年 10 月 28 日

A Study to Assess Efficacy, Safety of KAE609 in Adult Patients With Acute Malaria Mono-infection

计划入组 11 人 · 首次发布于 2013 年 5 月 23 日

The Efficacy and Safety Study of CAR-T Cells for Functional Cure in HIV-1/AIDS Patients

计划入组 3 人 · 首次发布于 2025 年 3 月 17 日

820TCR program (T-Cure Bioscience)

IL13Rα2 CAR-T(TCR CURE Biopharma)

C-Cure 709

CURE CMD

United States

T-Knife GmbH

Germany

PH & T SpA

Italy

ErVimmune Raises €17 Million to Advance Off-the-Shelf Cancer Vaccine Targeting Human Endogenous Retroviruses

Tempest Therapeutics Acquires Dual-CAR T Programs from Factor Bioscience in Strategic All-Stock Transaction

Integra Therapeutics and Factor Bioscience Showcase Advanced Gene-Editing Technologies for CAR-T Cell Therapies at ASGCT 2025